英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Rapid carotid plaques reversal of PCSK9 inhibitors when added to . . .
    Purpose: We attempt to determine whether triple combination of statins, EPA, PCSK9 inhibitors (PCSK9i) evolocumab henceforth known as Trio Combo could promote faster and larger carotid plaque regression Method: 57 patients with high risk cardio-cerebrovascular diseases were entered into the study Age between 55 to 88 years old, average age 72
  • Rapid carotid plaques reversal of PCSK9 inhibitors when added to . . .
    Rapid carotid plaques reversal of PCSK9 inhibitors when added to statins and eicosapentaenoic acid in high risk cardiovascular patients Session: Poster session 7 - Lipids Topic: Lipids (Epidemiology and Prevention) Speaker: Doctor A Chan (Henderson, Nevada, US) About the speaker Chanwell Clinic, Henderson, Nevada (United States of America)
  • Cleveland Clinic-Led Study Shows Reversal of Coronary Plaque Buildup . . .
    NEW ORLEANS: Cleveland Clinic researchers have found that adding the injectable cholesterol-lowering drug evolocumab (Repatha) to full doses of statin drugs reversed the buildup of cholesterol plaques in the coronary artery walls after 18 months of treatment
  • Effects of Different Intensive Lipid-Lowering Therapies on . . .
    Intensive lipid-lowering therapies that combine statins with PCSK9 inhibitors, such as alirocumab, are more effective in regressing carotid plaques and stabilizing plaque morphology compared to other treatments
  • Adding Alirocumab to High-Intensity Statin Therapy Significantly . . .
    Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures of plaque vulnerability that signal risk for future cardiac events, according to research presented at the American
  • The Effects on Plaque of Statins PCSK9 Inhibitors
    Our findings suggest that, over a longer term and among lower-risk patients undergoing serial coronary CTA, statins are associated with slower progression of overall coronary atherosclerosis volume, with increased plaque calcification and reduction of high-risk plaque features
  • Evaluation of Intensive Statins and PCSK9 Inhibitors on Intracranial . . .
    CONCLUSIONS: Combining proprotein convertase subtilisin kexin type 9 inhibitors with high-intensity statins may improve plaque stability and reduce lumen stenosis in patients with intracranial atherosclerotic stenosis Larger randomized controlled trials are needed to confirm these findings
  • PCSK9 inhibitors and ezetimibe with or without statin therapy for . . .
    Ezetimibe or PCSK9 inhibitors may reduce non-fatal myocardial infarction and stroke in adults at very high or high cardiovascular risk who are taking the maximally tolerated dose of statins or who are statin-intolerant
  • Yellow III Trial Finds That Lipid Lowering With a PCSK9 Inhibitor Could . . .
    A study offers evidence that aggressive lipid lowering with a PCSK9 inhibitor, along with a statin, can significantly reduce that threat and potentially help doctors identify patients who would benefit most from treatment to change their coronary plaque morphology and composition
  • Expert Consensus on the Diagnosis and Management of Carotid . . .
    those at high cardiovascular risk, daily cholesterol intake should be < 300 mg (approximately the amount non-statin agents (e g , cholesterol absorption inhibitors, PCSK9 inhibitors) is recommended Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta- analysis Chin Med 2023; 18: 152





中文字典-英文字典  2005-2009